Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease

  • Yoshimitsu Soga
  • Yusuke Tomoi
  • Kei Sato
  • Osamu Iida
  • Hiroyoshi Yokoi
Original Article


The safety and patency of endovascular treatment (EVT) in isolated common femoral artery (CFA) and popliteal artery (PA) remain poorly understood. We investigated the efficacy after EVT for isolated CFA and PA disease. This study was performed as a multicenter retrospective registry of a prospectively maintained database. Between January 2001 and December 2010, consecutive 183 patients (214 lesions; CFA 111, PA 103) who received endovascular procedure for de novo isolated CFA and PA disease were enrolled. The main endpoints of this study were primary and secondary patency after EVT. Procedure success was 95.8 %. The 1- and 5-year primary patencies for CFA (PA) lesions after EVT were 73.5 % (75.5 %) and 46.9 % (56.2 %), respectively. There was no significant difference of primary patency rate between CFA and PA (46.9 vs. 56.2 % at 5-year, p = 0.83). However, secondary patency significantly differed between CFA and PA (97.6 vs. 86.2 % at 5-year, p = 0.009). Stent placement was not effective for the reduction of restenosis in both CFA and PA lesion. On multivariate analysis to define the predictors of primary patency for the CFA, renal failure, coronary artery disease, calcified lesion and residual stenosis after EVT were independent predictors. Also, the predictors of primary patency for the PA were BMI, reference vessel diameter, anemia and residual stenosis after EVT. Short-term patency after EVT for isolated CFA and PA lesion seems to be feasible. However, long-term patency was not promising. Furthermore, stent placement does not improve the primary patency.


Common femoral artery Popliteal artery Endovascular therapy 


Conflict of interest

None of the authors have a real or perceived conflict of interest regarding the work in the manuscript.


  1. 1.
    Mukherjee D, Inahara T. Endarterectomy as the procedure of choice for atherosclerotic occlusive lesions of the common femoral artery. Am J Surg. 1989;157:498–500.PubMedCrossRefGoogle Scholar
  2. 2.
    Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48:872–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Baumann F, Ruch M, Willenberg T, Dick F, Do DD, Keo HH, et al. Endovascular treatment of common femoral artery obstructions. J Vasc Surg. 2011;53:1000–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Silva JA, White CJ, Quintana H, Collins TJ, Jenkins JS, Ramee SR. Percutaneous revascularization of the common femoral artery for limb ischemia. Catheter Cardiovasc Interv. 2004;62:230–3.PubMedCrossRefGoogle Scholar
  5. 5.
    Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011 16;58:792–8.Google Scholar
  6. 6.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.PubMedCrossRefGoogle Scholar
  7. 7.
    Vogel TR, Dombrovskiy VY, Carson JL, Graham AM. In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia. J Vasc Surg. 2011;54:109–15.PubMedCrossRefGoogle Scholar
  8. 8.
    Meltzer AJ, Shrikhande G, Gallagher KA, Aiello FA, Kahn S, Connolly P, et al. Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease. J Vasc Surg. 2012;55:353–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Kram HB, Gupta SK, Veith FJ, Wengerter KR, Panetta TF, Nwosisi C. Late results of two hundred seventeen femoropopliteal bypasses to isolated popliteal artery segments. J Vasc Surg. 1991;14:386–90.PubMedCrossRefGoogle Scholar
  10. 10.
    Stricker H, Jacomella V. Stent-assisted angioplasty at the level of the common femoral artery bifurcation: midterm outcomes. J Endovasc Ther. 2004;11:281–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Nagata S. Influence of stent fracture on the long-term patency in the femoro-popliteal artery: experience of 4 years. JACC Cardiovasc Interv. 2009;2:665–71.PubMedCrossRefGoogle Scholar
  12. 12.
    Scheinert D, Scheinert S, Sax J, Piorkowski C, Bräunlich S, Ulrich M, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Treiman GS, Ichikawa L, Treiman RL, Cohen JL, Cossman DV, Wagner WH. Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty. J Vasc Surg. 1994;20:577–85.PubMedCrossRefGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2013

Authors and Affiliations

  • Yoshimitsu Soga
    • 1
  • Yusuke Tomoi
    • 1
  • Kei Sato
    • 2
  • Osamu Iida
    • 2
  • Hiroyoshi Yokoi
    • 1
  1. 1.Department of CardiologyKokura Memorial HospitalKitakyushuJapan
  2. 2.Cardiovascular CenterKansai Rosai HospitalAmagasakiJapan

Personalised recommendations